# Xenon Pharmaceuticals Inc.: Form 8-K, filed Aug 9, 2023

- Company: [Xenon Pharmaceuticals Inc.](/companies/xene.md) (CIK 1582313)
- Form: 8-K
- Filed: 2023-08-09
- Accepted by EDGAR: Aug 9, 2023, 20:16 ET
- Period: 2023-08-09
- Accession: 0000950170-23-040608
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1582313/000095017023040608/xene-20230809.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1582313/000095017023040608/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1582313/000095017023040608/xene-20230809.htm

Filed Aug 9, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-040608. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.